Results 51 to 60 of about 98,444 (236)

Coronaviruses

open access: yes, 2022
Abstract This chapter begins by describing older coronaviruses, such as SARS and MERS, followed by the novel coronavirus SARS-CoV-2. Details of Pfizer’s mRNA vaccine are described and viral vector vaccines are also reviewed. This chapter will also discuss two small-molecule antiviral drugs: Gilead’s remdesivir and dexamethasone.
Schoeman, Dewald   +2 more
openaire   +2 more sources

Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022

open access: yesEmerging Infectious Diseases, 2023
We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only
Zeno Bisoffi   +9 more
doaj   +1 more source

Comparison of features of the 3 coronaviruses.

open access: yes, 2022
Comparison of features of the 3 coronaviruses.
C. Jessica E. Metcalf (8862062)   +3 more
core   +1 more source

Back to the Future: Immune Protection or Enhancement of Future Coronaviruses

open access: yesMicroorganisms
Before the emergence of SARS-CoV-1, MERS-CoV, and most recently, SARS-CoV-2, four other coronaviruses (the alpha coronaviruses NL63 and 229E and the beta coronaviruses OC43 and HKU1) had already been circulating in the human population. These circulating
Merit Bartels   +3 more
doaj   +1 more source

The Microbiology of Coronaviruses

open access: yesJournal of the Pakistan Medical Association, 2020
The end of 2019 marked the start of coronavirus disease (COVID-19) pandemic from China, which went on to envelope more than 190 countries and territories across the globe. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from a group of betacoronaviruses, is responsible for COVID-19.
openaire   +2 more sources

Inactivation of coronaviruses by heat [PDF]

open access: yesJournal of Hospital Infection, 2020
Indisponível.
Kampf, G., Voss, A., Scheithauer, S.
openaire   +3 more sources

[Human coronaviruses].

open access: yes, 2020
International audienceFour coronaviruses cause frequent and most often mild respiratory infections in humans: HCoV-OC43, HCoV-229E, HCoV-NL63 and HCoV-HKU 1.
Segondy, Michel, Michel Segondy
core   +1 more source

Conserved Targets to Prevent Emerging Coronaviruses

open access: yes, 2022
Novel coronaviruses emerged as zoonotic outbreaks in humans in 2003 (SARS), 2012 (MERS), and notably in 2019 (SARS2), which resulted in the COVID-19 pandemic, causing worldwide health and economic disaster.
Laura L. Newcomb   +4 more
core   +1 more source

Regulation of Lysosomal Associated Membrane Protein 3 (LAMP3) in Lung Epithelial Cells by Coronaviruses (SARS-CoV-1/2) and Type I Interferon Signaling

open access: yesComputational and Mathematical Biophysics, 2022
Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2) infection is a major risk factor for mortality and morbidity in critical care hospitals around the world.
Ramana Chilakamarti V., Das Bikul
doaj   +1 more source

تازه های علمی کرونا ویروس ها در سازمان بهداشت جهانی؛ (19) گروه اپیدمیولوژی دانشکده بهداشت و ایمنی دانشگاه علوم پزشکی شهید بهشتی و کرمان

open access: yesطب اورژانس ایران, 2020
مطالب علمی و اخبار از سایت سازمان جهانی بهداشت سخنان آغازین مدیرکل سازمان جهانی بهداشت در نشست خبری رسانه‌ای درباره COVID-19 10 آوریل 2020 در سطح جهان، در حال حاضر نزدیک به 5/1 میلیون مورد تائید شده و بیش از 92 هزار مرگ در اثر ابتلا به COVID-19 به
محمد آقاعلی   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy